2 results
Approved WMOCompleted
The main objective in this study is to examine if there is a difference in coagulation between Ringerlactaat/GelofusineĀ® priming and Ringerlactaat/HES 130/0.4 priming after coronary artery bypass graft (CABG), by measuring the thorax drainā¦
Approved WMOCompleted
The objective of the AUGMENT-HF study is to provide evidence for the safety profile associated with the Algisyl-LVR* device and initial evidence for the efficacy of the device.